Skip to content

Device-based QRS Evaluation

Device-based QRS Evaluation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02814214
Enrollment
103
Registered
2016-06-27
Start date
2016-06-30
Completion date
2017-09-30
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to collect simultaneous surface electrocardiogram (ECG) recordings and Cardiac Resynchronization Therapy (CRT) intracardiac electrogram (IEGM) recordings of variations in electrical synchrony.

Interventions

DEVICEECG+IEGM

Cardiac Resynchronization Therapy programming adjustments

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Already implanted with SJM Quadripolar CRT Pacing System * Ability to provide informed consent for study participation * Willing to comply with the study evaluation requirements * At least 18 years of age

Exclusion criteria

* Resting ventricular rate \>100 bpm * Intrinsic PR interval \> 300 ms * Paroxysmal or persistent atrial tachycardia or atrial fibrillation documented * Pregnant or plans to become pregnant during the study

Design outcomes

Primary

MeasureTime frame
Characterize CRT IEGM-based estimations of QRS durationAcute (1 day)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026